ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Cohance Lifesciences Limited has appointed Mr. Umang Vohra as Chairman effective May 1, 2026. This follows the resignation of Mr. Vivek Sharma as Executive Chairman on April 30, 2026, due to personal reasons. Mr. Vohra brings over 30 years of experience, including leadership roles at Cipla and Dr. Reddy's.
Cohance Lifesciences Limited has appointed Mr. Umang Vohra as Chairman and Group CEO. Mr. Vohra brings over 30 years of experience, including leadership roles at Cipla, Dr. Reddy's Laboratories, and PepsiCo India.
Cohance Lifesciences appointed Umang Vohra as Executive Chairman (effective May 1, 2026) and Group CEO (effective May 20, 2026). He succeeds Vivek Sharma, who is stepping down for personal reasons but will remain as an advisor for nine months to ensure a smooth transition. Mr. Vohra previously served as MD and CEO of Cipla.